{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:21:27Z","timestamp":1792880487694,"version":"4.5.0"},"publisher-location":"Chichester, UK","reference-count":180,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000402.pub3","type":"reference-entry","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T18:07:34Z","timestamp":1239818854000},"source":"Crossref","is-referenced-by-count":45,"title":["Hormone therapy in postmenopausal women and risk of endometrial hyperplasia"],"prefix":"10.1002","author":[{"given":"Susan","family":"Furness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Marjoribanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lethaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(16)58690-7","article-title":"Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: A randomised trial","volume":"66","author":"AinMelk","year":"1996","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/cmt.4.4.343.354","article-title":"Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: A comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate","volume":"4","author":"Al-Azzawi","year":"2001","journal-title":"Climacteric"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirinone-estradiol for hormone therapy: a randomised, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub3-BIB4|cit4","series-title":"Climacteric","first-page":"145","article-title":"A comparison of the effects of continuous combined regimens of 1mg 17B-estradiol and trimegestone with continuous combined estradiol and norethisterone acetate upon the bleeding profile and safety in postmenopausal women for up to 2 years","author":"Bouchard","year":"2002"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09513590500168464","article-title":"Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol\/trimegestone versus 1 or 2 mg 17beta-estradiol\/norethisterone acetate in postmenopausal women","volume":"21","author":"Bouchard","year":"2005","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09513590500128971","article-title":"Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate","volume":"21","author":"Gambacciani","year":"2005","journal-title":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-5122(01)00245-6","article-title":"Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy:a randomized comparative dose-ranging study","volume":"40","author":"Bruhat","year":"2001","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub3-BIB8|cit8","first-page":"523","article-title":"Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium","volume":"79","author":"Byrjalsen","year":"1992","journal-title":"Obstetrics & Gynecology"},{"issue":"3 I","key":"10.1002\/14651858.CD000402.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9378(99)70251-6","article-title":"Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy","volume":"180","author":"Byrjalsen","year":"1999","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"Suppl","key":"10.1002\/14651858.CD000402.pub3-BIB10|cit10","first-page":"19","article-title":"Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy","volume":"76","author":"Byrjalsen","year":"1997","journal-title":"Acta Obsterica et Gynecologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1471-0528.2000.tb13230.x","article-title":"Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium","volume":"107","author":"Byrjalsen","year":"2000","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00042192-200310020-00010","article-title":"Comparison of the difference in histopathology and cell cycle kinetics among the postmenopausal endometrium treated with different progestins in sequential-combined hormone replacement therapy","volume":"10","author":"Chang","year":"2003","journal-title":"Menopause"},{"issue":"7","key":"10.1002\/14651858.CD000402.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"The comparative effect on bone density, endometrium and lipids of continuous hormones as replacement therapy (CHART study). A randomised controlled trial","volume":"276","author":"Speroff","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000402.pub3-BIB14|cit14","first-page":"279","article-title":"Effect of a unique constant estrogen, pulsed progestin hormone replacement therapy containing 17B estradiol and norgestimate on endometrial histology","volume":"44","author":"Corson","year":"1999","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD000402.pub3-BIB15|cit15","first-page":"286","article-title":"Efficacy and safety of constant estrogen, pulsed progestin regimen in hormone replacement therapy","volume":"44","author":"Sulak","year":"1999","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD000402.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9378(92)91653-R","article-title":"Low-dosage micronized 17B-estradiol prevents bone loss in postmenopausal women","volume":"166","author":"Ettinger","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/cmt.5.1.26.35","article-title":"Endometrial safety and bleeding patterns during a 2 year study of 1 or 2 mg of 17B-estradiol combined with sequential 5-20mg dydrogesterone","volume":"5","author":"Ferenczy","year":"2002","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub3-BIB18|cit18","first-page":"398","article-title":"A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium","volume":"74","author":"Gelfand","year":"1989","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697130009167612","article-title":"Comparison of the efficacy and endometrial safety of two estradiol valerate\/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women","volume":"3","author":"Graser","year":"2000","journal-title":"Climacteric"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.gme.0000184425.73567.12","article-title":"Oral hormone therapy with 17s-estradiol and 17s-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects","volume":"12","author":"Greenwald","year":"2005","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/archinte.1991.00400100060010","article-title":"The effects of estrone (OGEN) on spinal bone density of postmenopausal women","volume":"151","author":"Harris","year":"1991","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000402.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5122(96)01098-5","article-title":"HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women","volume":"26","author":"Heikkinen","year":"1997","journal-title":"Maturitas"},{"issue":"167","key":"10.1002\/14651858.CD000402.pub3-BIB23|cit23","first-page":"P76.33","article-title":"Comparison of bleeding patterns and endometrial histology between a three monthly and monthly cycle HRT (abstract)","volume":"76","author":"Heikkinen","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica Supplement"},{"issue":"11","key":"10.1002\/14651858.CD000402.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s001980070031","article-title":"Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens","volume":"11","author":"Heikkinen","year":"2000","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD000402.pub3-BIB25|cit25","series-title":"International Journal of Obstetrics & Gynecology","first-page":"98","article-title":"Long-term endometrial safety of continuous combined HRT Results from a 7-year randomised study","author":"Heikkinen","year":"2003"},{"key":"10.1002\/14651858.CD000402.pub3-BIB26|cit26","doi-asserted-by":"crossref","unstructured":"Heikkinen J Vaheri R Timonen U A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings.[erratum appears in J Br Menopause Soc. 2006 Dec;12(4):174] Journal of the British Menopause Society 2006 115 25","DOI":"10.1258\/136218006778234093"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/1362180043654647","article-title":"Long-term safety and tolerability of continuous-combined hormone therapy in postmenopausal women: Results from a seven-year randomised comparison of low and standard doses","volume":"10","author":"Heikkinen","year":"2004","journal-title":"Journal of the British Menopause Society"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/mob.2000.104767","article-title":"Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens","volume":"182","author":"Heikkinen","year":"2000","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB29|cit29","series-title":"Climacteric","first-page":"210","article-title":"Long-term data on endometrial safety and bleeding control with a continuous combined Hrt regimen","author":"Weijer","year":"2002"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000402.pub3-BIB30|cit30","first-page":"239","article-title":"Improved amenorrhoea, favourable vasomotor and lipid effects, and endometrial safety with lower doses of conjugated estrogens (CE) and medroxyprogesterone acetate (MPA)","volume":"14","author":"Archer","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(01)01828-3","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"76","author":"Pickar","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD000402.pub3-BIB33|cit33","series-title":"Fertility & Sterility","first-page":"52","article-title":"Endometrial safety with lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA)","author":"Pickar","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(03)01167-1","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: Two-year substudy results","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.GME.0000117062.54779.BD","article-title":"Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women","volume":"11","author":"Utian","year":"2004","journal-title":"Menopause"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.","volume":"75","author":"Utian","year":"2001","journal-title":"Fertility & Sterility"},{"issue":"Suppl 1 (Abstra","key":"10.1002\/14651858.CD000402.pub3-BIB37|cit37","first-page":"144","article-title":"A comparative 2-year study of two sequential regimens of 1mg estradiol and trimegestone with 1mg estradiol and norethisterone upon profiles of endometrial bleeding and safety in postmenopausal women","volume":"5","author":"Koninckx","year":"2002","journal-title":"Climacteric"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/09513590500168472","article-title":"A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women","volume":"21","author":"Koninckx","year":"2005","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09513590500128815","article-title":"A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1mg 17 B-estradiol and trimegestone compared with a regimen containing 1mg estradiol valerate and norethisterone over a 2 year period","volume":"21","author":"Pornel","year":"2005","journal-title":"Gynaecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0029-7844(00)00944-3","article-title":"Norethindrone acetate and estradiol-induced endometrial hyperplasia","volume":"96","author":"Kurman","year":"2000","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB41|cit41","first-page":"207","article-title":"Evaluation of low-dose estrogen and progestin therapy in postmenopausal women","volume":"38","author":"Luciano","year":"1993","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13697130310001651481","article-title":"A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: Randomized comparison with a conventional-dose regimen","volume":"7","author":"Mattsson","year":"2004","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000402.pub3-BIB43|cit43","first-page":"146","article-title":"Bleeding control, endometrial safety and tolerability of various continuous combined HRT regimens (abstract)","volume":"5","author":"Vaheri","year":"2002","journal-title":"Climacteric"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/gye.15.5.349.358","article-title":"A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone","volume":"15","author":"Meuwissen","year":"2001","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB45|cit45","series-title":"International Journal of Obsterics and Gynecology","first-page":"120","article-title":"Effects of progestin dose and time since menopause on endometrial bleeding with continuous combine hormone replacement therapy","author":"Archer","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0029-7844(00)01036-X","article-title":"Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding","volume":"96","author":"Archer","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB47|cit47","first-page":"686","article-title":"Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate","volume":"83","author":"Archer","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0002-9378(97)70037-1","article-title":"Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy","volume":"177","author":"Pickar","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9378(13)90437-3","article-title":"Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone","volume":"170","author":"Woodruff","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1479-828X.1995.tb01841.x","article-title":"Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy - A study of bleeding pattern, endometrial response, serum lipid and bone density changes","volume":"35","author":"Nand","year":"1995","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy. Effects on bone, plasma estradiol concentrations, endometrium and lipid levels","volume":"157","author":"Genant","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000402.pub3-BIB52|cit52","series-title":"8th International Congress on the Menopause","first-page":"212","article-title":"A Two-Year Study with Low Dose, Continuous, Unopposed Esterified Estrogens: Prevention of Postmenopausal Bone Loss with Minimal Endometrial Effects","author":"Lucas","year":"1996"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00042192-199704020-00004","article-title":"Minimal endometrial proliferation over a two-year period in postmenopausal women taking 0.3mg of unopposed esterified estrogens","volume":"4","author":"Notelovitz","year":"1997","journal-title":"Menopause"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00042192-199704030-00003","article-title":"Low-dose unopposed estrogens: preliminary findings on the frequency and duration of vaginal bleeding in postmenopausal women receiving esterified estrogens over a two-year period","volume":"4","author":"Trabal","year":"1997","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-5122(93)90129-6","article-title":"A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment","volume":"16","author":"Obel","year":"1993","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0029-7844(98)00038-6","article-title":"Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy","volume":"91","author":"Nand","year":"1998","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB57|cit57","series-title":"8th International Congress on the Menopause","first-page":"27","article-title":"Combination Continuous Therapy - What is the Optimal MPA Dose? Effect on Bleeding Profiles and Endometrial Histology","author":"Webster","year":"1996"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/humrep\/16.6.1244","article-title":"A prospective randomised controlled study comparing two doses of gestodene in cyclic combined HRT preparations on endometrial physiology","volume":"16","author":"Okon","year":"2001","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/15246090050118161","article-title":"Postmenopausal hormone use following a 3-year randomised clinical trial","volume":"9","author":"Barrett-Connor","year":"2000","journal-title":"Journal of Womens Health & Gender-Based Medicine"},{"key":"10.1002\/14651858.CD000402.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/0197-2456(94)00119-N","article-title":"The postmenopausal estrogen\/progestin interventions (PEPI) trial. Overview","volume":"16","author":"Bush","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0197-2456(94)00033-Y","article-title":"Rationale, design, and conduct of the PEPI Trial","volume":"16","author":"Espeland","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1016\/0197-2456(94)00111-F","article-title":"Recruitment of postmenopausal women in the PEPI Trial","volume":"16","author":"Johnson","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub3-BIB63|cit63","first-page":"853","article-title":"Bleeding patterns of the hormone replacement therapies in postmenopausal estrogen and progestin interventions trial","volume":"100","author":"Lindenfield","year":"2002","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0029-7844(02)02245-7","article-title":"Bleeding patterns of the hormone replacement therapies in postmenopausal estrogen and progestin interventions trial","volume":"100","author":"Lindenfield","year":"2002","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1016\/0197-2456(94)00113-H","article-title":"Baseline characteristics of the PEPI participants","volume":"16","author":"Miller","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1016\/0197-2456(95)96882-C","article-title":"Physical and laboratory measurements in the PEPI Trial","volume":"16","author":"Wood","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen\/progestin interventions (PEPI) Trial","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000402.pub3-BIB68|cit68","series-title":"The 3rd World Congress on Controversies in Obstetrics, Gynecology & Infertility","first-page":"82","article-title":"Hormone replacement therapy (HRT) with 1 mg norethindrone acetate (NA) \/ 5 mcg ethinyl estradiol (EE) (FemHRT) provides greater protection against breakthrough bleeding versus 0.625 mg combined equine estrogens (CEE) \/ 2.5 mg medroxyprogesterone (MPA) (Prempro)","author":"Portman","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mob.2003.91","article-title":"A randomised, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone","volume":"188","author":"Portman","year":"2003","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD000402.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultralow-Dose Micronized 17beta-Estradiol and Bone Density and Bone Metabolism in Older Women: A Randomized Controlled Trial","volume":"290","author":"Prestwood","year":"2003","journal-title":"Jama"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13697130310001651445","article-title":"Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate\/medroxyprogesterone acetate therapy regimen","volume":"7","author":"Rees","year":"2004","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0020-7292(00)00342-8","article-title":"Constant estrogen, intermittent progestogen vs continuous combined hormone replacement: tolerability and effect on vasomotor symptoms","volume":"72","author":"Rozenberg","year":"2001","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"Suppl","key":"10.1002\/14651858.CD000402.pub3-BIB73|cit73","first-page":"S18","article-title":"One-year efficacy and safety of Prefect, a pulsed progestogen, constant estrogen hormone replacement therapy regimen","volume":"86","author":"Rozenberg","year":"1999","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB74|cit74","doi-asserted-by":"crossref","unstructured":"Ylikorkala O Lim P Caubel P Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol\/norethisterone acetate hormone replacement therapy Clinical Therapeutics 2000 622 36","DOI":"10.1016\/S0149-2918(00)80049-1"},{"key":"10.1002\/14651858.CD000402.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1034\/j.1600-0412.2002.810712.x","article-title":"Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate","volume":"81","author":"Ylikorkala","year":"2002","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD000402.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(99)00033-X","article-title":"Adverse endometrial effects during long cycle hormone replacement therapy","volume":"32","author":"Bjarnason","year":"1999","journal-title":"Maturitas"},{"issue":"10","key":"10.1002\/14651858.CD000402.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM199603073341018","article-title":"Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy (letter)","volume":"334","author":"Cerin","year":"1996","journal-title":"New England of Journal of Medicine"},{"key":"10.1002\/14651858.CD000402.pub3-BIB78|cit78","series-title":"8th International Congress on the Menopause","first-page":"48","article-title":"Adverse Endometrial Effects During Long Cycle Hormone Replacement Therapy","author":"Cerin","year":"1996"},{"issue":"10","key":"10.1002\/14651858.CD000402.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1988.tb06511.x","article-title":"Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints","volume":"95","author":"Sporrong","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5122(89)90212-0","article-title":"A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy","volume":"11","author":"Sporrong","year":"1989","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(95)00949-3","article-title":"17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy","volume":"23","author":"Stadberg","year":"1996","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13697139909025573","article-title":"Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone","volume":"2","author":"Weijer","year":"1999","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13697130310001651535","article-title":"Safety and efficacy of drospirinone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis","volume":"7","author":"Warming","year":"2004","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub3-BIB84|cit84","doi-asserted-by":"crossref","unstructured":"Anderson GL Judd HL Kaunitz AM Barad DH Beresford SAA Pettinger M Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.[see comment] JAMA 2003 1739 48","DOI":"10.1001\/jama.290.13.1739"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD000402.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB87|cit87","first-page":"787","article-title":"Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement","volume":"84","author":"Williams","year":"1994","journal-title":"Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB88|cit88","first-page":"267","article-title":"Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis","volume":"37","author":"Wu","year":"2002","journal-title":"Chinese Journal of Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub3-BIB89|cit89","first-page":"584","article-title":"A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin","volume":"116","author":"Xing","year":"2003","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00404-005-0099-6","article-title":"Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding","volume":"273","author":"Yildirim","year":"2006","journal-title":"Archives of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD000402.pub3-BIB91|cit91","series-title":"6th International Congress on the Menopause, Bangkok, Thailand, October\/November 1990","first-page":"151","article-title":"Assessment of oestrogen replacement therapy with conjugated oestrogens by histological evaluation of the endometrium in 205 women (abstract)","author":"Aoki","year":"1990"},{"key":"10.1002\/14651858.CD000402.pub3-BIB92|cit92","first-page":"323","article-title":"Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate","volume":"94","author":"Archer","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.maturitas.2003.08.013","article-title":"The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women","volume":"48","author":"Arrenbrecht","year":"2004","journal-title":"Maturitas"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB95|cit95","first-page":"354","article-title":"Double-blind study of the effect of continuous therapy with estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, lipid profile and endometrial thickness","volume":"59","author":"Blumel","year":"1994","journal-title":"Revista Chilena Obstetricia y Ginecologia"},{"key":"10.1002\/14651858.CD000402.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-5122(92)90060-H","article-title":"Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: Correlation with serum hormone concentrations and bleeding patterns","volume":"15","author":"Byrjalsen","year":"1992","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub3-BIB97|cit97","doi-asserted-by":"crossref","unstructured":"Byrjalsen I Thormann L Meinecke B Riis BJ Christiansen C Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy Human Reproduction 1992 1042 7","DOI":"10.1093\/oxfordjournals.humrep.a137791"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0306-3356(21)00374-5","article-title":"Oestrogen therapy and the menopausal syndrome","volume":"4","author":"Campbell","year":"1977","journal-title":"Clinics in Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB99|cit99","series-title":"8th International Congress on the Menopause, Sydney Australia","first-page":"191","article-title":"Bleeding Pattern in Two Combined Continuous Hormone Replacement Therapy (HRT) Regimes in Climacteric Women","author":"Campodonico","year":"1996"},{"key":"10.1002\/14651858.CD000402.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/humrep\/14.Suppl_3.246","article-title":"Effects of cyclic continuous and sequential post-menopausal hormone replacement therapy on uterine bleeding and climacteric symptoms","volume":"14","author":"Chen","year":"1999","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1002\/14651858.CD000402.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0002-9378(82)90176-4","article-title":"Dose-response evaluation of cyclic estrogen\/gestagen in postmenopausal women: Placebo-controlled trial of its gynaecologic and metabolic actions","volume":"144","author":"Christensen","year":"1982","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-5122(02)00037-3","article-title":"The effects of oral estriol on the endometrium in postmenopausal women","volume":"42","author":"Granberg","year":"2002","journal-title":"Maturitas"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB103|cit103","first-page":"205","article-title":"The effect of different postmenopausal hormone replacement treatment protocols on endometrial thickness","volume":"46","author":"Gulhan","year":"2004","journal-title":"Gulhane Medical Journal"},{"key":"10.1002\/14651858.CD000402.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00016348209156564","article-title":"Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period","volume":"61","author":"Hagen","year":"1982","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD000402.pub3-BIB105|cit105","series-title":"6th International Congress on the Menopause, Bangkok, Thailand, October\/November 1990","first-page":"086","article-title":"Continuous hormone replacement therapy with oestradiol valerate alone and in combination with cyproterone acetate: clinical and endometrial findings (abstract)","author":"Heytmanek","year":"1990"},{"key":"10.1002\/14651858.CD000402.pub3-BIB106|cit106","series-title":"8th International Congress on the Menopause; Sydney, Australia","first-page":"100","article-title":"Hormone Replacement Therapy after Transcervical Resection of the Endometrium","author":"Istre","year":"1996"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0029-7844(96)00308-0","article-title":"Hormone replacement therapy after transcervical resection of the endometrium","volume":"88","author":"Istre","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD000402.pub3-BIB108|cit108","first-page":"75","article-title":"Bleeding patterns in menopausal women taking HRT","volume":"F-13-03","author":"Jaisamrarn","year":"2002","journal-title":"Climacteric"},{"issue":"9","key":"10.1002\/14651858.CD000402.pub3-BIB109|cit109","first-page":"857","article-title":"Effect of combined oral estrogen\/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naive Thai women","volume":"82","author":"Jirapinyo","year":"2003","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB110|cit110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/09513590400002318","article-title":"The comparison of bleeding patterns with high-dose and low-dose hormone replacement therapy in postmenopausal women","volume":"19","author":"Kazerooni","year":"2004","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB111|cit111","series-title":"The 1st scientific meeting of the Asia-Pacific Menopause Federation","first-page":"61","article-title":"Comparison of the incidence of irregular bleeding during treatment with a low dose continuous combined or sequential hormone replacement therapy","author":"Holst","year":"2002"},{"key":"10.1002\/14651858.CD000402.pub3-BIB112|cit112","first-page":"407","article-title":"Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women","volume":"83","author":"Limpaphayom","year":"2000","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ajog.2004.12.067","article-title":"The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial... includes discussion. Am J Obstet Gynecol","volume":"192","author":"Liu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/14651858.CD000402.pub3-BIB114|cit114","first-page":"39","article-title":"Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy","volume":"71","author":"Luciano","year":"1988","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2362.1991.tb01416.x","article-title":"Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding","volume":"21","author":"Marslew","year":"1991","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD000402.pub3-BIB116|cit116","first-page":"202","article-title":"Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding","volume":"79","author":"Marslew","year":"1992","journal-title":"Obstetrics and Gynecology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD000402.pub3-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0002-9378(91)90677-J","article-title":"Bleeding patterns during continuous combined estrogen-progestogen therapy","volume":"164","author":"Marslew","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/14651858.CD000402.pub3-BIB118|cit118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(97)01110-9","article-title":"Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen\/progestin therapy: a 2-year prospective study","volume":"27","author":"Mizunuma","year":"1997","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub3-BIB119|cit119","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.GME.0000109314.11228.E5","article-title":"Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study","volume":"11","author":"Crisafulli","year":"2004","journal-title":"Menopause"},{"issue":"10","key":"10.1002\/14651858.CD000402.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1359\/jbmr.2002.17.10.1904","article-title":"Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study","volume":"17","author":"Morabito","year":"2002","journal-title":"Journal of Bone & Mineral Research"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB121|cit121","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00006250-197907000-00017","article-title":"Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems","volume":"54","author":"Nachtigall","year":"1979","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB122|cit122","series-title":"Gynecological Endocrinology","first-page":"128","article-title":"Bleeding patterns in postmenopausal women using two types of continuous combined hormone replacement therapy (abstract)","author":"Odmark","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB123|cit123","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1067\/mob.2001.112561","article-title":"Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17B-estradiol and norethindrone acetate","volume":"184","author":"Odmark","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB124|cit124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mob.2003.335","article-title":"Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: A pilot study","volume":"189","author":"Pinto","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.maturitas.2005.04.004","article-title":"Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy","volume":"53","author":"Popp","year":"2006","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0015-0282(16)45981-9","article-title":"Endometrial hyperplasia in women on cyclic or continuous estrogen regimens","volume":"37","author":"Schiff","year":"1982","journal-title":"Fertility and sterility"},{"key":"10.1002\/14651858.CD000402.pub3-BIB127|cit127","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00042192-200109000-00005","article-title":"Unscheduled bleeding during initiation of continuous combined hormone replacement therapy:a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens","volume":"8","author":"Simon","year":"2001","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/mob.2003.104","article-title":"Reduced vaginal bleeding in postmenopausal women who recieve combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy","volume":"188","author":"Simon","year":"2003","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.AOG.0000251518.56369.eb","article-title":"Unopposed estradiol therapy in postmenopausal women: Results from two randomized trials","volume":"109","author":"Steiner","year":"2007","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5122(00)00219-X","article-title":"17beta-Estradiol (1 mg\/day) continuously combined with dydrogesterone (5, 10 or 20 mg\/day) increases bone mineral density in postmenopausal women","volume":"38","author":"Stevenson","year":"2001","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub3-BIB131|cit131","series-title":"8th International Congress on the Menopause","first-page":"S36","article-title":"Bleeding patterns and endometrial histology with sequential HRT","author":"Sturdee","year":"1996"},{"key":"10.1002\/14651858.CD000402.pub3-BIB132|cit132","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1471-0528.2000.tb11654.x","article-title":"The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy","volume":"11","author":"Sturdee","year":"2000","journal-title":"British Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB133|cit133","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0029-7844(00)00941-8","article-title":"Vaginal bleeding in postmenopausal women taking low dose norethindrone acetate and ethinyl estradiol combinations","volume":"96","author":"Symons","year":"2000","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB134|cit134","first-page":"84","article-title":"Comparative effect of norethindrone acetate\/ethinyl estradiol and 0.625 mg conjugated estrogen\/2.5 mg medroxyprogesterone acetate on bleeding control: early results from a randomized placebo controlled trial.","volume":"Supplement","author":"Symons","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB135|cit135","series-title":"Climacteric","first-page":"146","article-title":"Bleeding control, endometrial safety and adherence to continuous combined HRT after 5 years","author":"Ulla Timonen","year":"2002"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD000402.pub3-BIB136|cit136","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/S0015-0282(02)03812-8","article-title":"Efficacy and safety study of a new synthetic 10-component, modified release conjugated estrogens(CE) tablet for treatment of vasomotor symptoms in postmenopausal women","volume":"78","author":"Utian","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD000402.pub3-BIB137|cit137","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-5122(86)90040-X","article-title":"Benefits and risks of different hormonal replacement therapies in post-menopausal women","volume":"6","author":"Volpe","year":"1986","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub3-BIB138|cit138","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0378-5122(02)00203-7","article-title":"Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone","volume":"43","author":"Holst","year":"2002","journal-title":"Maturitas"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub3-BIB139|cit139","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/humrep\/17.5.1386","article-title":"The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study","volume":"17","author":"Wahab","year":"2002","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB140|cit140","first-page":"256","article-title":"Profiles of irregular bleeding induced by low-dose hormone therapy and Chinese formulated herb products","volume":"28","author":"Wang","year":"2006","journal-title":"Acta Academiae Medicinae Sinicae"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB141|cit141","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.GME.0000097846.95550.AA","article-title":"Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women","volume":"11","author":"Warming","year":"2004","journal-title":"Menopause"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub3-BIB142|cit142","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0002-9378(90)90917-V","article-title":"Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient","volume":"162","author":"Weinstein","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB143|cit143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.325.7358.239","article-title":"Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study","volume":"325","author":"Wells","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000402.pub3-BIB144|cit144","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-9378(90)90402-S","article-title":"A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement","volume":"162","author":"Williams","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub3-BIB145|cit145","first-page":"23","article-title":"Effects of period free hormone replacement therapy in postmenopausal women in Taiwan","volume":"65","author":"Yang","year":"2001","journal-title":"Chinese Medical Journal (Taipei)"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000402.pub3-BIB146|cit146","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0015-0282(03)01849-1","article-title":"Impact of conjugated estrogens (CE)\/trimegestone (TMG) on endometrial hyperplasia and bleeding profiles in a double-blind, randomized, placebo-controlled study","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertility & Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000402.pub3-BIB147|cit147","first-page":"210","article-title":"Long-term data on endometrial safety and bleeding control with a continuous combined HRT regimen","volume":"5","author":"Weijer","year":"2002","journal-title":"Climacteric. 10th World Congress on Menopause"},{"key":"10.1002\/14651858.CD000402.pub3-BIB148|cit148","series-title":"8th International Congress on the Menopause; Sydney, Australia","first-page":"47","article-title":"Sequential Three-Monthly Versus Monthly HRT: A Prospective Double-Blind Randomised Study","author":"Mooren","year":"1996"},{"key":"10.1002\/14651858.CD000402.pub3-BIB149|cit149","series-title":"8th International Congress on the Menopause","first-page":"27","article-title":"Combination Continuous Therapy - What is the Optimal MPA Dose? Effect on Bleeding Profiles and Endometrial Histology","author":"Webster","year":"1996"},{"key":"10.1002\/14651858.CD000402.pub3-BIB150|cit150","first-page":"14","article-title":"Estrogens; conjugated and esterified therapeutic substitution","volume":"19","author":"Ansbacher","year":"1994","journal-title":"Femal Pat"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB151|cit151","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM197901043000103","article-title":"Endometrial cancer and estrogen use. Report of a large case-control study","volume":"300","author":"Antunes","year":"1979","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB152|cit152","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0029-7844(99)00358-0","article-title":"Uterine bleeding in postmenopausal women on continuous therapy with oestradiol and norethindrone acetate","volume":"94","author":"Archer","year":"1999","journal-title":"Obstet gynecol"},{"key":"10.1002\/14651858.CD000402.pub3-BIB153|cit153","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-199005050-00004","article-title":"A risk benefit assessment of oestrogen therapy in post menopausal women","volume":"5","author":"Cust","year":"1990","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD000402.pub3-BIB154|cit154","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/oxfordjournals.bmb.a072553","article-title":"HRT: Developments in therapy","volume":"48","author":"Ellerington","year":"1992","journal-title":"Br Med Bull"},{"key":"10.1002\/14651858.CD000402.pub3-BIB155|cit155","unstructured":"France J Personal communication"},{"key":"10.1002\/14651858.CD000402.pub3-BIB156|cit156","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM197709152971102","article-title":"Oestrogen and endometrial carcinoma: An independent pathology review supporting original size estimate","volume":"297","author":"Gardan","year":"1977","journal-title":"N Eng J Med"},{"key":"10.1002\/14651858.CD000402.pub3-BIB157|cit157","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"9483","key":"10.1002\/14651858.CD000402.pub3-BIB158|cit158","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(05)66519-1","article-title":"Treatment of menopausal symptoms: what shall we do now?","volume":"366","author":"Hickey","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000402.pub3-BIB159|cit159","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1002\/14651858.CD000402.pub3-BIB160|cit160","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]","author":"Higgins","year":"2008"},{"issue":"(10-11)","key":"10.1002\/14651858.CD000402.pub3-BIB161|cit161","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD000402.pub3-BIB162|cit162","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behaviour of endometrial hyperplasia. A long term study of 'untreated' hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000402.pub3-BIB163|cit163","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJM197606032942304","article-title":"Estrogens and endometrial cancer in a retirement community","volume":"294","author":"Mack","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000402.pub3-BIB164|cit164","unstructured":"MacLennan AH Personal communication"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub3-BIB165|cit165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004861","article-title":"Progestogens in combined oral contraceptives for contraception","author":"Maitra","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000402.pub3-BIB166|cit166","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/13697139809085526","article-title":"A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II An assessment of treatment effects","volume":"1","author":"O'Connell","year":"1998","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub3-BIB167|cit167","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13697130400012288","article-title":"Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomised clinical trials.","volume":"8","author":"Peeyananjarassri","year":"2005","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub3-BIB168|cit168","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/89.15.1110","article-title":"Estrogen-progestin replacement therapy and endometrial cancer","volume":"89","author":"Pike","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub3-BIB169|cit169","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-0528.2002.01167.x","article-title":"Intrauterine 10mug and 20mug levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: Clinical, endometrial and metabolic response","volume":"109","author":"Raudaskoski","year":"2002","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"7596","key":"10.1002\/14651858.CD000402.pub3-BIB170|cit170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.39153.522535.BE","article-title":"Managing the menopause","volume":"334","author":"Roberts","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000402.pub3-BIB171|cit171","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","article-title":"Association of exogenous oestrogen and endometrial carcinoma","volume":"293","author":"Smith","year":"1977","journal-title":"N Eng J Med"},{"key":"10.1002\/14651858.CD000402.pub3-BIB172|cit172","volume-title":"Clinical gynecologic endocrinology and infertility (7th edition)","author":"Speroff","year":"2005"},{"issue":"8928","key":"10.1002\/14651858.CD000402.pub3-BIB173|cit173","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(94)91640-3","article-title":"Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestogen replacement therapy?","volume":"344","author":"Sturdee","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000402.pub3-BIB174|cit174","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1447-0756.1997.tb00836.x","article-title":"The behaviour of endometrial hyperplasia: a prospective study","volume":"28","author":"Terakawa","year":"1997","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1002\/14651858.CD000402.pub3-BIB175|cit175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0029-7844(95)00115-8","article-title":"Combined continuous hormone replacement therapy: a clinical review","volume":"86","author":"Udoff","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD000402.pub3-BIB176|cit176","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00016347709156348","article-title":"The effects of cyclical oestrogen therapy and sequential oestrogen therapy on the endometrium of postmenopausal women","volume":"65","author":"Whitehead","year":"1977","journal-title":"Acta Obst Gynae Scand Supp"},{"key":"10.1002\/14651858.CD000402.pub3-BIB177|cit177","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198112313052701","article-title":"Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium","volume":"305","author":"Whitehead","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000402.pub3-BIB178|cit178","doi-asserted-by":"crossref","first-page":"13113","DOI":"10.1016\/0002-9378(87)90170-0","article-title":"Controversies concerning the safety of estrogen replacement therapy","volume":"156","author":"Whitehead","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"7644","key":"10.1002\/14651858.CD000402.pub3-BIB179|cit179","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood L. Egger M. Gluud LL. Schulz KF. Juni P. Altman DG. Gluud C. Martin RM. Wood AJ. Sterne","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000402.pub3-BIB180|cit180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","article-title":"Increased risk of endometrial carcinoma amongst users of conjugated oestrogens","volume":"293","author":"Ziel","year":"1975","journal-title":"N Eng J Med"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000402.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000402.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T16:46:36Z","timestamp":1710261996000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000402.pub3"}},"subtitle":[],"editor":[{"given":"Susan","family":"Furness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":180,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000402.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000402.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,4,15]]}}}